User:Z3418340: Difference between revisions
No edit summary |
|||
| Line 39: | Line 39: | ||
==Individual Assessment 2 == | ==Individual Assessment 2 == | ||
[[ | [[File:Abnormal heart and caudal fin development in zebrafish due to Rap 1 knock down.png|800px]] | ||
Image:Abnormal heart and caudal fin development in zebrafish due to Rap 1 knock down<ref><pubmed>23226434</pubmed>| [http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0050960]</ref> | Image:Abnormal heart and caudal fin development in zebrafish due to Rap 1 knock down<ref><pubmed>23226434</pubmed>| [http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0050960]</ref> | ||
| Line 45: | Line 45: | ||
<references/> | <references/> | ||
==Pub Med== | ==Pub Med== | ||
Revision as of 10:57, 20 August 2014
--Z3418340 (talk) 12:45, 6 August 2014 (EST)
Lab Attendance
Lab 1 - --Z3418340 (talk) 12:53, 6 August 2014 (EST) Lab 2 - --Z3418340 (talk) 11:13, 13 August 2014 (EST)
Individual Assessment 1
ARTICLE 1
<pubmed>24302192</pubmed>
Inositol is an important factor with in the follicular environment, high levels have been associated with improved development of the oocyte. This particular study aims to understand the effects of treatment with inositol on oocyte quality in patients undergoing ICSI.
The researchers selected 149 patients undergoing ICSI cycles between June 2012 and May 2013, all of whom where aged under 40, had at least one previously failed attempt at ICSI and were diagnosed with polycystic ovary syndrome (PCOS). Patients were randomly divided into two groups. Group 1 consisting of 58 patients were treated with both folic acid (400 mg/day) and inositol (2000 mg/day of myo-inositol, D-chiro-inositol 400 mg/day) for 3 months prior to the ISCI cycles. Group 2 consisted of 91 patients who were treaded with folic acid (400 mg/day) alone, this group acted as the control.
(1.) The standard of IVF using ICSI was employed. Oocyte quality was routinely checked by making observations using an inverted microscope. The oocyte’s stage of maturity, size and shape, cytoplasmic characteristics and extracytoplasmic characterises were noted. (2.) Post-implantation assessments were made regarding embryo quality in light of the following parameters; number of blastomeres, degree of fragmentation and size of blastomeres. (3.) Finally at 14 days from Embryo-Transfer execution, quantitative blood detection of β-hCG is performed in order to biochemically determine pregnancy. This is followed by a final diagnosis of clinical pregnancy with ultrasound visualization.
(1.) No significant difference was found in the number of mature oocytes taken and in the number of immature oocytes taken. However the the results did show that a greater proportion of Group 1 oocytes displayed features that typical of excellent and good quality oocytes. (3.) In terms of the number of positive biochemical pregnancies there was again no statistically significant difference between Group 1 and Group 2. However Group 1 did show a statically significant increase in the number of clinical pregnancies detected.
The article is concluded discussing and highlighting the improvement in the overall quality of oocytes and parallel increase in the number of clinical pregnancies as a result of treatment with inositol.
ARTICLE 2
<pubmed>25077107 </pubmed>
The investigation was carried out on IVF patients from Mount Sinai Hospital, Toronto, Ontario. Candidates selected for the study were aged 18-41 years, with base line levels of FSH (on Day 3 of Cycle) and the ability to provide informed consent. Researchers included 173 female patients, who then underwent IVF cycles as per standard procedure.
Serum 25-hydroxy-vitamin D (25[OH]D) levels were measured one week prior to oocyte retrieval, these measurements taken in order to determine the initial Vitamin D status. Patients were either classified as having sufficient (≥ 75 nmol/L) or insufficient (< 75 nmol/L) 25(OH)D levels.
Standard IVF procedures followed; oocyte retrieval, fertilisation, growth and embryo transfer. An ultrasound was then taken 4-5 weeks after the embryo was transferred and implantation success was monitored, as indicate by the presence of a gestational sac, visible by ultrasonography. The implantation rate was calculated as the number of gestational sacs observed by ultrasonography divided by the number of embryos transferred, multiplied by 100.
With in this cohort 45.1% had sufficient levels of 25(OH)D, while 54.9% had insufficient levels. The study found a 52.5% clinical pregnancy rate per IVF cycle among women with sufficient levels of 25(OH)D levels. This was significantly higher than compare to a rate of 34.7% the among women with insufficient levels of 25(OH)D.
Individual Assessment 2
Image:Abnormal heart and caudal fin development in zebrafish due to Rap 1 knock down[1]
Pub Med
http://www.ncbi.nlm.nih.gov/pubmed/25084016
<pubmed>25084016</pubmed>
